Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Overview 6 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Therapeutics Development 7 Pipeline Overview 7 Pipeline by Companies 8 Products under Development by Companies 11 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Therapeutics Assessment 14 Assessment by Target 14 Assessment by Mechanism of Action 16 Assessment by Route of Administration 18 Assessment by Molecule Type 20 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Companies Involved in Therapeutics Development 22 3SBio Inc 22 Amgen Inc 22 arGEN-X BV 23 Biogen Inc 23 Boehringer Ingelheim GmbH 24 Bristol-Myers Squibb Company 24 CSL Ltd 25 Dova Pharmaceuticals Inc 25 Enzene Biosciences Ltd 26 Genosco Inc 26 GlaxoSmithKline Plc 27 Hansa Medical AB 27 Immunomedics Inc 28 Intas Pharmaceuticals Ltd 28 Jiangsu Hengrui Medicine Co Ltd 29 Momenta Pharmaceuticals Inc 30 Novartis AG 31 Pfizer Inc 32 Pharmagenesis Inc 32 Protalex Inc 33 Rigel Pharmaceuticals Inc 33 UCB SA 34 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Drug Profiles 35 avatrombopag - Drug Profile 35 belimumab - Drug Profile 38 BI-655064 - Drug Profile 46 efgartigimod alfa - Drug Profile 48 eltrombopag olamine - Drug Profile 51 eltrombopag olamine - Drug Profile 58 fostamatinib disodium - Drug Profile 59 GL-2045 - Drug Profile 65 Hetrombopag Olamine - Drug Profile 67 KLM-465 - Drug Profile 68 letolizumab - Drug Profile 70 M-230 - Drug Profile 71 M-254 - Drug Profile 72 M-281 - Drug Profile 73 PBF-1650 - Drug Profile 74 PHN-013 - Drug Profile 75 PRTX-100 - Drug Profile 76 Recombinant Enzyme to Inhibit Immunoglobulin G for Autoimmune Diseases - Drug Profile 83 rituximab - Drug Profile 84 romiplostim - Drug Profile 91 romiplostim biosimilar - Drug Profile 95 romiplostim biosimilar - Drug Profile 96 rozanolixizumab - Drug Profile 97 SKIO-703 - Drug Profile 98 thrombopoietin - Drug Profile 100 veltuzumab - Drug Profile 101 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Dormant Projects 105 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Discontinued Products 106 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Product Development Milestones 107 Featured News & Press Releases 107 Appendix 117 Methodology 117 Coverage 117 Secondary Research 117 Primary Research 117 Expert Panel Validation 117 Contact Us 117 Disclaimer 118

List of Tables Number of Products under Development for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura), H2 2017 Number of Products under Development by Companies, H2 2017 Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017 Products under Development by Companies, H2 2017 Products under Development by Companies, H2 2017 (Contd..1), H2 2017 Number of Products by Stage and Target, H2 2017 Number of Products by Stage and Mechanism of Action, H2 2017 Number of Products by Stage and Route of Administration, H2 2017 Number of Products by Stage and Molecule Type, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by 3SBio Inc, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by Amgen Inc, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by arGEN-X BV, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by Biogen Inc, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by Boehringer Ingelheim GmbH, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by Bristol-Myers Squibb Company, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by CSL Ltd, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by Dova Pharmaceuticals Inc, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by Enzene Biosciences Ltd, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by Genosco Inc, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by GlaxoSmithKline Plc, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by Hansa Medical AB, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by Immunomedics Inc, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by Intas Pharmaceuticals Ltd, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by Momenta Pharmaceuticals Inc, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by Novartis AG, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by Pfizer Inc, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by Pharmagenesis Inc, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by Protalex Inc, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by Rigel Pharmaceuticals Inc, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline by UCB SA, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Dormant Projects, H2 2017 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Discontinued Products, H2 2017

3SBio Inc Amgen Inc arGEN-X BV Biogen Inc Boehringer Ingelheim GmbH Bristol-Myers Squibb Company CSL Ltd Dova Pharmaceuticals Inc Enzene Biosciences Ltd Genosco Inc GlaxoSmithKline Plc Hansa Medical AB Immunomedics Inc Intas Pharmaceuticals Ltd Jiangsu Hengrui Medicine Co Ltd Momenta Pharmaceuticals Inc Novartis AG Pfizer Inc Pharmagenesis Inc Protalex Inc Rigel Pharmaceuticals Inc UCB SA